BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36528403)

  • 1. Eosinophilic otitis media; state-of-the-art diagnosis and treatment.
    Iino Y
    Auris Nasus Larynx; 2023 Aug; 50(4):479-489. PubMed ID: 36528403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease.
    Iino Y; Tomioka-Matsutani S; Matsubara A; Nakagawa T; Nonaka M
    Auris Nasus Larynx; 2011 Aug; 38(4):456-61. PubMed ID: 21251776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intractable otitis media - Pathogenesis and treatment of Eosinophilic otitis media (EOM) and otitis media with Antineutrophil cytoplasmic antibody (ANCA) -associated vasculitis (OMAAV).
    Yoshida N
    Auris Nasus Larynx; 2023 Apr; 50(2):171-179. PubMed ID: 35934599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors associated with severity of eosinophilic otitis media.
    Kanazawa H; Yoshida N; Yamamoto H; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Iino Y
    Auris Nasus Larynx; 2014 Dec; 41(6):513-7. PubMed ID: 25199747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Insights into Eosinophilic Otitis Media.
    Kanazawa H; Yoshida N; Iino Y
    Curr Allergy Asthma Rep; 2015 Dec; 15(12):76. PubMed ID: 26546407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media.
    Iino Y; Takahashi E; Ida S; Kikuchi S
    Auris Nasus Larynx; 2019 Apr; 46(2):196-203. PubMed ID: 30122651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilic otitis media: a new middle ear disease entity.
    Iino Y
    Curr Allergy Asthma Rep; 2008 Nov; 8(6):525-30. PubMed ID: 18940145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of eosinophilic otitis media: a systematic review.
    Chen T; Ashman PE; Bojrab DI; Johnson AP; Hong RS; Benson B; Svider PF
    Acta Otolaryngol; 2021 Jun; 141(6):579-587. PubMed ID: 33825596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dupilumab improves eosinophilic otitis media associated with eosinophilic chronic rhinosinusitis.
    Nakashima D; Nakayama T; Minagawa S; Adachi T; Mitsuyama C; Shida Y; Nakajima T; Haruna SI; Matsuwaki Y
    Allergol Int; 2023 Oct; 72(4):557-563. PubMed ID: 37061391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical diagnosis and treatment of eosinophilic otitis media].
    Zhang YZ; Wei XY; Chen ZC; Sun M; Cheng Y; Gao Y; Chen FY; Hu J; Xu M; Zhang Q; Fan MY
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):160-163. PubMed ID: 30808144
    [No Abstract]   [Full Text] [Related]  

  • 11. Eosinophilic otitis media: CT and MRI findings and literature review.
    Chung WJ; Lee JH; Lim HK; Yoon TH; Cho KJ; Baek JH
    Korean J Radiol; 2012; 13(3):363-7. PubMed ID: 22563277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eustachian tube function in patients with eosinophilic otitis media associated with bronchial asthma evaluated by sonotubometry.
    Iino Y; Kakizaki K; Saruya S; Katano H; Komiya T; Kodera K; Ohta K
    Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1109-14. PubMed ID: 17043260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab.
    Suzaki I; Kimura Y; Tanaka A; Hirano K; Ishibashi A; Mizuyoshi T; Ando I; Kitajima T; Watanabe S; Hinohira Y; Kobayashi H
    Auris Nasus Larynx; 2019 Feb; 46(1):141-146. PubMed ID: 29909018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dupilumab therapy for patients with refractory eosinophilic otitis media associated with bronchial asthma.
    Iino Y; Sekine Y; Yoshida S; Kikuchi S
    Auris Nasus Larynx; 2021 Jun; 48(3):353-360. PubMed ID: 32943257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete Remission of Severe Eosinophilic Otitis Media With Dupilumab: A Case Report.
    van der Lans RJL; van Spronsen E; Fokkens WJ; Reitsma S
    Laryngoscope; 2021 Dec; 131(12):2649-2651. PubMed ID: 34216146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilic otitis media is associated with asthma severity and smoking history.
    Seo Y; Nonaka M; Tagaya E; Tamaoki J; Yoshihara T
    ORL J Otorhinolaryngol Relat Spec; 2015; 77(1):1-9. PubMed ID: 25633710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical observation of the course of eosinophilic otitis media against the background of biological therapy of chronic polypous rhinosinusitis].
    Fedin AV
    Vestn Otorinolaringol; 2024; 89(2):95-100. PubMed ID: 38805470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher Prevalence and Severity of Eosinophilic Otitis Media in Patients with Asthma-COPD Overlap Compared with Asthma Alone.
    Sato E; Seo Y; Tagaya E; Yagi O; Yamamura Y; Nonaka M
    Int Arch Allergy Immunol; 2023; 184(11):1116-1125. PubMed ID: 37619543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eosinophilic otitis media and eosinophilic chronic -hinosinusitis].
    Matsubara A; Takahata J; Kudo N; Noro M; Miura T
    Nihon Rinsho; 2016 Oct; 74(10):1717-1720. PubMed ID: 30551286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periostin in middle ear mucosa according to eosinophilic otitis media severity: Middle ear pathology-based treatment.
    Esu Y; Masuda M; Yoshida N
    Auris Nasus Larynx; 2020 Aug; 47(4):527-535. PubMed ID: 32586742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.